The available clinical experience with tigecycline is analyzed under the perspective of a systematic review of the literature, related to the already approved indications reported ill the recent literature. The safety profile is checked in the above mentioned clinical trials. The available information allows supporting tigecycline efficiency in the managing of complicated skin and Soft tissues infections, complicated intrabdominales infections and in community acquired pneumonias.